2323 related items for PubMed ID: 15835375
1. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
Suzuki H, Kanno Y, Nakamoto H, Okada H, Sugahara S.
Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
[Abstract] [Full Text] [Related]
2. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
Minutolo R, Gabbai FB, Borrelli S, Scigliano R, Trucillo P, Baldanza D, Laurino S, Mascia S, Conte G, De Nicola L.
Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091
[Abstract] [Full Text] [Related]
3. Effects of multiple factorial intervention on ambulatory BP profile and renal function in hypertensive type 2 diabetic patients with overt nephropathy - a pilot study.
Kanaoka T, Tamura K, Moriya T, Tanaka K, Konno Y, Kondoh S, Toyoda M, Umezono T, Fujikawa T, Ohsawa M, Dejima T, Maeda A, Wakui H, Haku S, Yanagi M, Mitsuhashi H, Ozawa M, Okano Y, Ogawa N, Yamakawa T, Mizushima S, Suzuki D, Umemura S.
Clin Exp Hypertens; 2011 Dec; 33(4):255-63. PubMed ID: 21699452
[Abstract] [Full Text] [Related]
4. Morning home blood pressure may be a significant marker of nephropathy in Japanese patients with type 2 diabetes: ADVANCED-J study 1.
Tanaka Y, Daida H, Imai Y, Miyauchi K, Sato Y, Hiwatari M, Kitagawa A, Kishimoto J, Yamazaki T, Kawamori R.
Hypertens Res; 2009 Sep; 32(9):770-4. PubMed ID: 19557003
[Abstract] [Full Text] [Related]
5. Effects of gender, Helicobacter pylori and hepatitis B virus serology status on cardiovascular and renal complications in Chinese type 2 diabetic patients with overt nephropathy.
Lo MK, Lee KF, Chan NN, Leung WY, Ko GT, Chan WB, So WY, Ng MC, Ho CS, Tam JS, Lam CW, Tong PC, Chan JC.
Diabetes Obes Metab; 2004 May; 6(3):223-30. PubMed ID: 15056131
[Abstract] [Full Text] [Related]
6. Strict blood-pressure control and progression of renal failure in children.
ESCAPE Trial Group, Wühl E, Trivelli A, Picca S, Litwin M, Peco-Antic A, Zurowska A, Testa S, Jankauskiene A, Emre S, Caldas-Afonso A, Anarat A, Niaudet P, Mir S, Bakkaloglu A, Enke B, Montini G, Wingen AM, Sallay P, Jeck N, Berg U, Caliskan S, Wygoda S, Hohbach-Hohenfellner K, Dusek J, Urasinski T, Arbeiter K, Neuhaus T, Gellermann J, Drozdz D, Fischbach M, Möller K, Wigger M, Peruzzi L, Mehls O, Schaefer F.
N Engl J Med; 2009 Oct 22; 361(17):1639-50. PubMed ID: 19846849
[Abstract] [Full Text] [Related]
7. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.
Salako BL, Finomo FO, Kadiri S, Arije A, Olatosin AO.
Afr J Med Med Sci; 2002 Mar 22; 31(1):53-7. PubMed ID: 12518931
[Abstract] [Full Text] [Related]
8. [Risk and prevention of diabetic nephropathy].
Ravera M, Re M, Deferrari G.
G Ital Nefrol; 2007 Mar 22; 24 Suppl 38():13-9. PubMed ID: 17922442
[Abstract] [Full Text] [Related]
9. Reproducibility of renal function measurements in adult men with diabetic nephropathy: research and clinical implications.
Agarwal R.
Am J Nephrol; 2007 Mar 22; 27(1):92-100. PubMed ID: 17284896
[Abstract] [Full Text] [Related]
10. Treatment of hypertension in chronic kidney disease.
Toto RD.
Semin Nephrol; 2005 Nov 22; 25(6):435-9. PubMed ID: 16298269
[Abstract] [Full Text] [Related]
11. Proteinuria predicts end-stage renal failure in non-diabetic chronic nephropathies. The "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN).
Ruggenenti P, Perna A, Mosconi L, Matalone M, Pisoni R, Gaspari F, Remuzzi G.
Kidney Int Suppl; 1997 Dec 22; 63():S54-7. PubMed ID: 9407422
[Abstract] [Full Text] [Related]
12. [Spirapril - a new long-acting ACE inhibitor: efficacy and safety in patients with arterial hypertension in combination with diabetes mellitus and impaired kidney function].
Iakusevich VV, Mozheĭko ME, Paliutin ShKh, Berezina MIu, Martsevich SIu, Shal'nova SA, Deev AD, Kutishenko NP, Alimova EV, Koniakhina IP, Semenova IuE.
Ter Arkh; 2000 Dec 22; 72(10):82-6. PubMed ID: 11220887
[Abstract] [Full Text] [Related]
13. Predictors of mortality in patients with type 2 diabetes with or without diabetic nephropathy: a follow-up study.
Astrup AS, Nielsen FS, Rossing P, Ali S, Kastrup J, Smidt UM, Parving HH.
J Hypertens; 2007 Dec 22; 25(12):2479-85. PubMed ID: 17984670
[Abstract] [Full Text] [Related]
14. Spironolactone in type 2 diabetic nephropathy: Effects on proteinuria, blood pressure and renal function.
van den Meiracker AH, Baggen RG, Pauli S, Lindemans A, Vulto AG, Poldermans D, Boomsma F.
J Hypertens; 2006 Nov 22; 24(11):2285-92. PubMed ID: 17053552
[Abstract] [Full Text] [Related]
15. Risk factors of renal failure progression two years prior to dialysis.
Mazouz H, Kacso I, Ghazali A, El Esper N, Moriniere P, Makdassi R, Hardy P, Westeel PF, Achard JM, Pruna A, Fournier A.
Clin Nephrol; 1999 Jun 22; 51(6):355-66. PubMed ID: 10404696
[Abstract] [Full Text] [Related]
16. Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-beta levels.
Agarwal R, Siva S, Dunn SR, Sharma K.
Am J Kidney Dis; 2002 Mar 22; 39(3):486-92. PubMed ID: 11877567
[Abstract] [Full Text] [Related]
17. The bedtime administration of doxazosin controls morning hypertension and albuminuria in patients with type-2 diabetes: evaluation using home-based blood pressure measurements.
Kamoi K, Ikarashi T.
Clin Exp Hypertens; 2005 May 22; 27(4):369-76. PubMed ID: 15921073
[Abstract] [Full Text] [Related]
18. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist.
Martínez-Ramírez HR, Jalomo-Martínez B, Cortés-Sanabria L, Rojas-Campos E, Barragán G, Alfaro G, Cueto-Manzano AM.
Am J Kidney Dis; 2006 Jan 22; 47(1):78-87. PubMed ID: 16377388
[Abstract] [Full Text] [Related]
19. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
Esnault VL, Brown EA, Apetrei E, Bagon J, Calvo C, DeChatel R, Holdaas H, Krcmery S, Kobalava Z, Amlodipine Versus Enalapril in Renal failure (AVER) Study Group.
Clin Ther; 2008 Mar 22; 30(3):482-98. PubMed ID: 18405787
[Abstract] [Full Text] [Related]
20. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
Vogt L, Kocks MJ, Laverman GD, Navis G.
Minerva Med; 2004 Oct 22; 95(5):395-409. PubMed ID: 15467515
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
